Mei Yue, Juanjuan Li, Junhui Li, Tao Hu, Shunqiao Feng, Jing Cao, Ruihong Tang, Pengpeng Wang, Fengjiao Zhu, Lu Han, Jian Wu, Xiaodai Cui, Rong Liu
{"title":"EB病毒感染者与免疫缺陷患者外周血和骨髓液免疫反应的比较分析:回顾性病例研究。","authors":"Mei Yue, Juanjuan Li, Junhui Li, Tao Hu, Shunqiao Feng, Jing Cao, Ruihong Tang, Pengpeng Wang, Fengjiao Zhu, Lu Han, Jian Wu, Xiaodai Cui, Rong Liu","doi":"10.1097/MD.0000000000039501","DOIUrl":null,"url":null,"abstract":"<p><p>High-throughput immune repertoire (IR) sequencing provides direct insight into the diversity of B cell receptor (BCR) and T cell receptor (TCR), with great potential to revolutionize the diagnosis, monitoring, and prevention of immune system-related disorders. In this study, multiplex PCR was applied to amplify the complementarity-determining regions of BCR and TCR, followed by comprehensive analysis by high-throughput sequencing. We compare the TCR (BCR) of bone marrow fluid (BMF) and peripheral blood (PB) samples from 17 patients in the Epstein-Barr and immunodeficiency groups, respectively. Our study shows that the diversity of the IR of blood samples is very similar to that of bone marrow samples statistically. However, the distributions of the monoclonal genes are significantly different in these 2 samples of most patients. This suggests that the BMFs can be replaced by the PB samples in diversity detection of IR to monitor the immune status of the body, while the detection of the BMFs is unreplaceable when the monoclonal change occurs. We used high-throughput sequencing to assess the TCR and BCR of the patients and provide a basis for the clinical analysis of PB and bone marrow samples and selection of disease diagnosis and monitoring methods.</p>","PeriodicalId":18549,"journal":{"name":"Medicine","volume":"103 38","pages":"e39501"},"PeriodicalIF":2.0000,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11419465/pdf/","citationCount":"0","resultStr":"{\"title\":\"Comparative analysis of the immune repertoire between peripheral blood and bone marrow fluids in those infected by EBV and immunodeficiency: A retrospective case study.\",\"authors\":\"Mei Yue, Juanjuan Li, Junhui Li, Tao Hu, Shunqiao Feng, Jing Cao, Ruihong Tang, Pengpeng Wang, Fengjiao Zhu, Lu Han, Jian Wu, Xiaodai Cui, Rong Liu\",\"doi\":\"10.1097/MD.0000000000039501\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>High-throughput immune repertoire (IR) sequencing provides direct insight into the diversity of B cell receptor (BCR) and T cell receptor (TCR), with great potential to revolutionize the diagnosis, monitoring, and prevention of immune system-related disorders. In this study, multiplex PCR was applied to amplify the complementarity-determining regions of BCR and TCR, followed by comprehensive analysis by high-throughput sequencing. We compare the TCR (BCR) of bone marrow fluid (BMF) and peripheral blood (PB) samples from 17 patients in the Epstein-Barr and immunodeficiency groups, respectively. Our study shows that the diversity of the IR of blood samples is very similar to that of bone marrow samples statistically. However, the distributions of the monoclonal genes are significantly different in these 2 samples of most patients. This suggests that the BMFs can be replaced by the PB samples in diversity detection of IR to monitor the immune status of the body, while the detection of the BMFs is unreplaceable when the monoclonal change occurs. We used high-throughput sequencing to assess the TCR and BCR of the patients and provide a basis for the clinical analysis of PB and bone marrow samples and selection of disease diagnosis and monitoring methods.</p>\",\"PeriodicalId\":18549,\"journal\":{\"name\":\"Medicine\",\"volume\":\"103 38\",\"pages\":\"e39501\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2024-09-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11419465/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/MD.0000000000039501\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MD.0000000000039501","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
摘要
高通量免疫复合物(IR)测序可直接了解B细胞受体(BCR)和T细胞受体(TCR)的多样性,在诊断、监测和预防免疫系统相关疾病方面具有巨大的变革潜力。本研究采用多重 PCR 技术扩增了 BCR 和 TCR 的互补决定区,然后通过高通量测序进行了综合分析。我们分别比较了 17 例 Epstein-Barr 组和免疫缺陷组患者的骨髓液(BMF)和外周血(PB)样本中的 TCR(BCR)。我们的研究表明,从统计学角度看,血液样本的 IR 多样性与骨髓样本非常相似。然而,在大多数患者的这两种样本中,单克隆基因的分布却明显不同。这表明,在对 IR 进行多样性检测时,骨髓样本可以替代 BMF 来监测机体的免疫状态,而当发生单克隆变化时,BMF 的检测则无法替代。我们利用高通量测序技术评估了患者的TCR和BCR,为临床分析PB和骨髓样本、选择疾病诊断和监测方法提供了依据。
Comparative analysis of the immune repertoire between peripheral blood and bone marrow fluids in those infected by EBV and immunodeficiency: A retrospective case study.
High-throughput immune repertoire (IR) sequencing provides direct insight into the diversity of B cell receptor (BCR) and T cell receptor (TCR), with great potential to revolutionize the diagnosis, monitoring, and prevention of immune system-related disorders. In this study, multiplex PCR was applied to amplify the complementarity-determining regions of BCR and TCR, followed by comprehensive analysis by high-throughput sequencing. We compare the TCR (BCR) of bone marrow fluid (BMF) and peripheral blood (PB) samples from 17 patients in the Epstein-Barr and immunodeficiency groups, respectively. Our study shows that the diversity of the IR of blood samples is very similar to that of bone marrow samples statistically. However, the distributions of the monoclonal genes are significantly different in these 2 samples of most patients. This suggests that the BMFs can be replaced by the PB samples in diversity detection of IR to monitor the immune status of the body, while the detection of the BMFs is unreplaceable when the monoclonal change occurs. We used high-throughput sequencing to assess the TCR and BCR of the patients and provide a basis for the clinical analysis of PB and bone marrow samples and selection of disease diagnosis and monitoring methods.
期刊介绍:
Medicine is now a fully open access journal, providing authors with a distinctive new service offering continuous publication of original research across a broad spectrum of medical scientific disciplines and sub-specialties.
As an open access title, Medicine will continue to provide authors with an established, trusted platform for the publication of their work. To ensure the ongoing quality of Medicine’s content, the peer-review process will only accept content that is scientifically, technically and ethically sound, and in compliance with standard reporting guidelines.